Synthesis and in Vitro Biological Activities of 4,5-Disubstituted 1,2,4-Triazole-3-Thiols

Humaira Nadeem; Muhammad Mohsin; Hasan Afzaal; Sadaf Riaz; Ammar Zahid; Syed Aun Muhammad

doi:10.4236/aim.2013.34050

Home > Journals > Biomedical & Life Sciences > AiM

AiM> Vol.3 No.4, August 2013

Share This Article:

Synthesis and in Vitro Biological Activities of 4,5-Disubstituted 1,2,4-Triazole-3-Thiols ()

Abstract Full-Text HTML

Download as PDF (Size:321KB) PP. 366-375

DOI: 10.4236/aim.2013.34050 3,703 Downloads 6,151 Views Citations

Author(s) Leave a comment

Humaira Nadeem, Muhammad Mohsin, Hasan Afzaal, Sadaf Riaz, Ammar Zahid, Syed Aun Muhammad

Affiliation(s)

.
Department of Pharmaceutics, Riphah Institute of Pharmaceutical Sciences, Riphah International University Islamabad, Islamabad, Pakistan.

ABSTRACT

Purpose: The triazole nucleus is an important part of the therapeutically interesting drug candidate as antimicrobial, analgesic, anticancer, anticonvulsant and anti-inflammatory agents. Methods: Therefore, in this study, twelve 4,5-disubstituted-1,2,4-triazole-3-thiols were synthesized by the reaction of substituted isothiocyanates and hydrazides using the common method of base catalysed intramolecular dehydrative cyclization of substituted thiosemicarbazides 3(a-f) and 4(a-f). The structures of these compounds were characterized by means of FT-IR, ¹H-NMR, and elemental analysis data. All these compounds were screened for antibacterial, antioxidant, antitumor and cytotoxic activities. Results: Among these compounds: 5c, 5f and 6f were found active against gram positive cocci, the compounds 5a, 5b, 5d, 6a and 6f showed 85% free radical scavenging effect at 3 ppm when tested for antioxidant activity, 75% tumors inhibition was recorded using 5c, 5d and 6a and brine shrimps lethality assay declared 5a, 5b and 6d was 129.62 μg/ml, 161.577 μg/ml and 81.56 μg/ml respectively. Conclusion: Compounds carrying significant bioactivity can be further studied using animal models to establish their safety profile prior to initiating clinical trials.

KEYWORDS

4, 5-Disubstituted 1, 2, 4-Triazole-3-Thiols; Antibacterial; Antitumor; Antioxidant; Cytotoxic

Cite this paper

H. Nadeem, M. Mohsin, H. Afzaal, S. Riaz, A. Zahid and S. Muhammad, "Synthesis and in Vitro Biological Activities of 4,5-Disubstituted 1,2,4-Triazole-3-Thiols," Advances in Microbiology, Vol. 3 No. 4, 2013, pp. 366-375. doi: 10.4236/aim.2013.34050.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	N. D. Heindel and J. R. Reid, “4-Amino-3-Mercapto-4H-1,2,4-Triazoles and Propargyl Aldehydes: A New Route to 3-R-8-Aryl-1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazepines,” Journal of Heterocyclic Chemistry, Vol. 17, No. 5, 1980, p. 1087. doi:10.1002/jhet.5570170547

[2]	B. S. Holla, B. Kalluraya, K. R. Sridhar, E. Drake, L. M. Thomas, K. K. Bhandary and M. S. Levine, “Synthesis, Structural Characterization, Crystallographic Analysis and Antibacterial Properties of Some Nitrofuryl Triazolo [3,4-b]-1,3,4-Thiadiazines,” European Journal of Medicinal Chemistry, Vol. 29, No. 4, 1994, pp. 301-308.

[3]	J. Haber, “Present Status and Perspectives on Antimycoties with Systematic Effects,” Casopis Lekaru Ceskych, Vol. 140, No. 19, 2001, pp. 596-604.

[4]	A. Brucato, A. Coppola, S. Gianguzza and P. M. Provenzan, “Triazolam: Characteristics of Its Depressive Action,” Bollettino della Società italiana di biologia sperimentale, Vol. 54, No. 11, 1978, pp. 1051-1057.

[5]	D. L. Coffen and R. I. Fryer, US Patent (1974) 3(849): 434, Chemical Abstracts, 1975, 82: 730044v.

[6]	M. Shiroki, T. Tahara and K. Araki, Japanese Patent NO. 75100096, 1975, Chemical Abstracts, 84: 59588k.

[7]	F. D. Povelitsa and A. G. Gural, “Antibiotiki,” Moscow, 1973;18,71; Chemical Abstracts, 78, 93044.

[8]	R. M. Shaker. “The Chemistry of Mercaptoand ThioneSubstituted 1,2,4-Triazoles and Their Utility in Heterocyclic Synthesis,” ARKIVOC, No. 9, 2006, pp. 59-112. doi:10.3998/ark.5550190.0007.904

[9]	G. Mazzone, F. Bonina, R. R. Arrigo and G. Blandino “Synthesis of 1-Aroyl-4H(R)-Thiosemicarbazides, the Corresponding 5-Aryl 4H(R)-1,2,4-Triazolin-3-Thiones and Some Derivatives of Pharmaceutical Interest,” Farmaco-Edizione Scientifica, Vol. 36, No. 3, 1981, pp. 181-196.

[10]	S. Narayanaswami and K. Richardson, European Patent, 1983, 96:569; Chemical Abstracts, 1984. 100: 139122t.

[11]	M. B. Gravestock, European Patent, 1983, 94:146, Chemical Abstracts, 1984, 100: 139118w.

[12]	R. Sharma, D. P. Nagde and G. L. Talesara, ARKIVOC, Vol. 1, 2006, pp. 1-12.

[13]	K. S. Sen, F. S. Haque and C. S. Pal, “Nutrient Optimization for Production of Broad Spectrum Antibiotics by Streptomyces Antibiotics Strain 154,” Acta Microbiologica et Immunologica Hungarica, Vol. 42, No. 2, 1995, pp. 155-162.

[14]	A. W. Bauer, W. M. Kirby, J. C. Sherries and M. Truck, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology, Vol. 45, No. 4, 1996, pp. 426-493.

[15]	A. Braca, N. De Tommasi, L. Di Bari, C. Pizza, M. Politi and I. Morelli, “Antioxidant Principles from Bauhinia Terapotensis,” Journal of Natural Products, Vol. 64, No. 7, 2001, pp. 892-895. doi:10.1021/np0100845

[16]	J. L. Mclaughlin and L. L. Rogers, “The Use of Biological Assays to Evaluate Botanicals,” Drug Information Journal, Vol. 32, No. 2, 1998, pp. 513-524.

[17]	B. N. Meyer, N. R. Ferrigni, J. E. Putnam, L. B. Jacobsen, D. E. Nichols and J. L. McLaughlin, “Brine Shrimp: A Convenient General Bioassay for Active Plant Constituents,” Planta Medica, Vol. 45, No. 5, 1982, pp. 31-34. doi:10.1055/s-2007-971236

[18]	D. J. Finney, “Probit Analysis,” Cambridge University Press, Cambridge, 1971.

[19]	H. O. Oladimeji, R. Nia and E. E. Essien, “In Vitro Anti-Microbial and Brine-Shrimp Lethality Potential of the Leaves and Stem of Calotropis procera (Ait),” African Journal of Biomedical Research, Vol. 9, No. 3, 2006, pp. 205-211.